Immunovant, Inc. (IMVT)
USD 15.8
(-0.63%)
USD 15.8
(-0.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -635.22 Million USD | -69.25% |
| 2023 | -375.31 Million USD | 23.63% |
| 2022 | -491.45 Million USD | -23.88% |
| 2021 | -396.72 Million USD | -307.4% |
| 2020 | -97.38 Million USD | -389424.0% |
| 2019 | -25 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -690.63 Million USD | -156.44% |
| 2024 FY | -635.22 Million USD | -69.25% |
| 2024 Q1 | -329.04 Million USD | 12.33% |
| 2024 Q2 | -269.31 Million USD | 18.15% |
| 2024 Q4 | -635.22 Million USD | 8.02% |
| 2023 Q2 | -403.97 Million USD | 4.97% |
| 2023 FY | -375.31 Million USD | 23.63% |
| 2023 Q4 | -375.31 Million USD | 12.94% |
| 2023 Q3 | -431.09 Million USD | -6.71% |
| 2023 Q1 | -425.12 Million USD | 13.5% |
| 2022 Q2 | -555.91 Million USD | -47.87% |
| 2022 Q1 | -375.94 Million USD | 5.24% |
| 2022 Q3 | -524.24 Million USD | 5.7% |
| 2022 Q4 | -491.45 Million USD | 6.25% |
| 2022 FY | -491.45 Million USD | -23.88% |
| 2021 FY | -396.72 Million USD | -307.4% |
| 2021 Q2 | -440.59 Million USD | -59.52% |
| 2021 Q4 | -396.72 Million USD | 5.2% |
| 2021 Q3 | -418.47 Million USD | 5.02% |
| 2021 Q1 | -276.2 Million USD | -183.63% |
| 2020 Q1 | 3.08 Million USD | 1929.01% |
| 2020 Q2 | 36.29 Million USD | 1075.35% |
| 2020 FY | -97.38 Million USD | -389424.0% |
| 2020 Q3 | -120.63 Million USD | -432.35% |
| 2020 Q4 | -97.38 Million USD | 19.27% |
| 2019 Q4 | 152.2 Thousand USD | 0.0% |
| 2019 FY | -25 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -774.992% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 486.466% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 133.97% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -843114.219% |
| Apollomics, Inc. | -27.39 Million USD | -2218.77% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -96773.256% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -618.095% |
| Bicycle Therapeutics plc | -481.46 Million USD | -31.936% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -391.989% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1856.566% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 15384.577% |
| Chimerix, Inc. | -25.51 Million USD | -2389.427% |
| CRISPR Therapeutics AG | -150.84 Million USD | -321.112% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 457.54% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -130.327% |
| Fortress Biotech, Inc. | 7.66 Million USD | 8387.371% |
| Fortress Biotech, Inc. | 7.66 Million USD | 8387.371% |
| Gritstone bio, Inc. | 39.49 Million USD | 1708.577% |
| Allakos Inc. | -24.97 Million USD | -2443.451% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -2853.033% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -6945.552% |
| Cytokinetics, Incorporated | 642.37 Million USD | 198.888% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -785.42% |
| Innoviva, Inc. | 255.56 Million USD | 348.56% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -6776.845% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 86400.277% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -1465.678% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -11222.581% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -700.811% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -1565.427% |
| ImmuCell Corporation | 10.99 Million USD | 5879.75% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -312.094% |
| Incyte Corporation | -3.17 Billion USD | 79.993% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 4095.545% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -53364.211% |
| Mustang Bio, Inc. | -3.73 Million USD | -16902.864% |
| MiMedx Group, Inc. | -33.9 Million USD | -1773.771% |
| MEI Pharma, Inc. | -3.7 Million USD | -17045.128% |
| MacroGenics, Inc. | -66.98 Million USD | -848.312% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -8642.362% |
| Mereo BioPharma Group plc | -51.46 Million USD | -1134.193% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -4103.614% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -6119.18% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1864.274% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1649.174% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -2757.264% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -24928.645% |
| NextCure, Inc. | -6.47 Million USD | -9707.426% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -2100.149% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -1157.85% |
| Onconetix, Inc. | 5.33 Million USD | 12014.743% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -9858.097% |
| Opthea Limited | 28.15 Million USD | 2355.982% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 3450.317% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 9313.402% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1842.062% |
| Precigen, Inc. | -481 Thousand USD | -131963.825% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -3551.569% |
| Prime Medicine, Inc. | -27.94 Million USD | -2173.458% |
| PureTech Health plc | -167.19 Million USD | -279.927% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1958.282% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -2244.011% |
| Replimune Group, Inc. | 1.41 Million USD | 45087.748% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -5197.222% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 2385.565% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -27315.606% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -4.443% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -3329.978% |
| Sesen Bio, Inc. | -112.55 Million USD | -464.38% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -8846.859% |
| Solid Biosciences Inc. | -47.75 Million USD | -1230.318% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -116.241% |
| SciSparc Ltd. | -2.06 Million USD | -30661.598% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 659.765% |
| TG Therapeutics, Inc. | 17.86 Million USD | 3656.304% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -4097.073% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -10132.394% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 283.27% |
| UroGen Pharma Ltd. | 4.39 Million USD | 14566.568% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -2542.705% |
| XOMA Corporation | -29 Million USD | -2090.438% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 3681.771% |
| AbCellera Biologics Inc. | -55.94 Million USD | -1035.551% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -4484.49% |
| Cassava Sciences, Inc. | -121.13 Million USD | -424.392% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 9216.247% |
| Precision BioSciences, Inc. | -85.41 Million USD | -643.738% |
| Dyadic International, Inc. | -6.37 Million USD | -9859.504% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -7464.027% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -3886.864% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1985.446% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1810.055% |
| IGM Biosciences, Inc. | -72.6 Million USD | -774.896% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -1442.375% |
| Acelyrin, Inc. | -216.9 Million USD | -192.862% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -6901.29% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -3683.59% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -7335.49% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -100.521% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -720.166% |
| Senti Biosciences, Inc. | 1.74 Million USD | 36607.299% |
| Mesoblast Limited | 55.96 Million USD | 1235.084% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -2411.573% |
| ChromaDex Corporation | -24.04 Million USD | -2541.496% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -73584.62% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 1136.987% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -8440.138% |
| Seer, Inc. | -4.24 Million USD | -14881.769% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 492.741% |
| Novavax, Inc. | -298.29 Million USD | -112.953% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -6848.818% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 1130.109% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -12790.158% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -670.159% |
| Celcuity Inc. | 6.78 Million USD | 9464.283% |
| ContextLogic Inc. | -232 Million USD | -173.805% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -162.097% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -474.674% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 113.838% |
| Amarin Corporation plc | -191.04 Million USD | -232.51% |
| AnaptysBio, Inc. | -18.15 Million USD | -3399.68% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -5420.353% |
| Aptorum Group Limited | 1.35 Million USD | 46909.541% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -863.107% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 14941.752% |
| Ardelyx, Inc. | 34.51 Million USD | 1940.597% |
| Celularity Inc. | 65.19 Million USD | 1074.424% |
| Omeros Corporation | 331.17 Million USD | 291.809% |
| Humacyte, Inc. | -22.48 Million USD | -2724.989% |
| Immunocore Holdings plc | -358.59 Million USD | -77.144% |
| IO Biotech, Inc. | -140.69 Million USD | -351.479% |
| GT Biopharma, Inc. | -1.02 Million USD | -62116.161% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -237.492% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1931.998% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -10378.835% |
| Pulmatrix, Inc. | -10.41 Million USD | -5997.984% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -470.211% |
| Evogene Ltd. | -19.63 Million USD | -3135.342% |
| CorMedix Inc. | -43.05 Million USD | -1375.47% |
| BioLineRx Ltd. | 7.33 Million USD | 8759.038% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -442.716% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -746.134% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -254.925% |
| scPharmaceuticals Inc. | -6.54 Million USD | -9605.531% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -4208.961% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -369.148% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 86400.277% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -3329.978% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -205.157% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -584.785% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -2750.085% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -244.097% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -2282.786% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 5322.503% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -3705.54% |
| Daré Bioscience, Inc. | -5.15 Million USD | -12215.587% |
| bluebird bio, Inc. | 108.57 Million USD | 685.08% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 267.718% |
| DBV Technologies S.A. | -126.98 Million USD | -400.234% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -262.51% |
| Galecto, Inc. | -21.21 Million USD | -2894.094% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -9237.454% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -592.496% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -837.148% |
| GlycoMimetics, Inc. | -40.98 Million USD | -1449.923% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 644.824% |
| ADMA Biologics, Inc. | 90.06 Million USD | 805.291% |
| Clene Inc. | 3.34 Million USD | 19118.772% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -84.592% |
| Aptose Biosciences Inc. | -8.19 Million USD | -7651.532% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -20201.162% |
| Soligenix, Inc. | -4.95 Million USD | -12728.73% |
| Century Therapeutics, Inc. | 847 Thousand USD | 75097.285% |
| Kura Oncology, Inc. | -20.11 Million USD | -3057.506% |
| Surrozen, Inc. | -32.66 Million USD | -1844.731% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -1452.136% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 34970.107% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -19769.471% |
| Autolus Therapeutics plc | -186.59 Million USD | -240.424% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -1188.388% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1953.703% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -2582.886% |
| GRI Bio, Inc. | -1.79 Million USD | -35308.417% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -6971.399% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 12002.323% |
| INmune Bio, Inc. | -25.41 Million USD | -2399.811% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 520.817% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1153.927% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3809.24% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -6736.847% |
| Jaguar Health, Inc. | 29.39 Million USD | 2261.298% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -21918.832% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1770.99% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 4611.235% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 2092.244% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 268.071% |
| Verastem, Inc. | -37.27 Million USD | -1604.027% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -1124.841% |
| Histogen Inc. | -7.48 Million USD | -8384.4% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -2839.937% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -383.239% |
| Surrozen, Inc. | -32.66 Million USD | -1844.731% |
| Organovo Holdings, Inc. | -1.5 Million USD | -42051.758% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -15011.902% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -7479.234% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -1362.242% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -4257.777% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -87874.268% |
| Kronos Bio, Inc. | -36.05 Million USD | -1661.877% |
| Turnstone Biologics Corp. | -14.58 Million USD | -4255.643% |
| Synaptogenix, Inc. | -28.66 Million USD | -2116.308% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -67766.132% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 101250.796% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 1403.511% |
| Exelixis, Inc. | -73.05 Million USD | -769.578% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -2545.346% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -163.175% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -655.314% |
| ESSA Pharma Inc. | -33.62 Million USD | -1789.343% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -24033.481% |
| Avid Bioservices, Inc. | 169.72 Million USD | 474.262% |
| Insmed Incorporated | 721.62 Million USD | 188.028% |
| MediWound Ltd. | -5.32 Million USD | -11835.87% |
| OmniAb, Inc. | 9.2 Million USD | 7002.391% |
| Alector, Inc. | -35.63 Million USD | -1682.493% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 838.885% |
| Zai Lab Limited | -775 Million USD | 18.035% |
| AlloVir, Inc. | -62.69 Million USD | -913.25% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 286.527% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -4722.922% |
| Aura Biosciences, Inc. | -21.52 Million USD | -2851.113% |
| Immunic, Inc. | -45.34 Million USD | -1301.03% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -228.767% |
| Veracyte, Inc. | -203.82 Million USD | -211.655% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 199.52% |
| FibroGen, Inc. | 56.76 Million USD | 1219.008% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 7233.375% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -373.771% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -22369.352% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -30582.137% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -18913.08% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -282.75% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 140.476% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -2495.73% |
| XBiotech Inc. | -200.02 Million USD | -217.577% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -655.314% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -100.575% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -36746.114% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 14128.865% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -1701.398% |
| Agenus Inc. | 274.13 Million USD | 331.72% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -722.641% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 11261.957% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -272.753% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -587.669% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 186.277% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -5799.457% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -1042.207% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -18298.122% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -6976.908% |
| Lantern Pharma Inc. | -21.7 Million USD | -2826.871% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -14920.738% |
| Ainos, Inc. | 4.07 Million USD | 15677.2% |
| Pluri Inc. | 22.82 Million USD | 2882.544% |
| Prothena Corporation plc | -608.34 Million USD | -4.419% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -434.901% |
| Rallybio Corporation | -24.1 Million USD | -2535.578% |
| Kodiak Sciences Inc. | -103.87 Million USD | -511.53% |
| Cue Biopharma, Inc. | -33.81 Million USD | -1778.314% |
| MeiraGTx Holdings plc | -40.3 Million USD | -1476.167% |
| Annexon, Inc. | -193.75 Million USD | -227.851% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -3530.076% |
| Moderna, Inc. | -2.9 Billion USD | 78.148% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -2484.85% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1955.684% |
| Blueprint Medicines Corporation | 702.83 Million USD | 190.381% |
| Immix Biopharma, Inc. | -17.5 Million USD | -3527.839% |
| CalciMedica, Inc. | -5.53 Million USD | -11386.926% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -674.082% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -1486.6% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -277.588% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1810.285% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -10527.857% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -959.701% |
| Nutriband Inc. | -251.65 Thousand USD | -252317.775% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -1761.798% |
| Vor Biopharma Inc. | 4.3 Million USD | 14872.721% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 89.476% |
| Alkermes plc | -166.73 Million USD | -280.971% |
| ProKidney Corp. | -56.23 Million USD | -1029.574% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -1205.118% |
| Arcellx, Inc. | -296.95 Million USD | -113.911% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 146.574% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -2212.86% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 1476.529% |
| Atai Life Sciences N.V. | -28.55 Million USD | -2124.34% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 28578.76% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -2684.13% |
| MediciNova, Inc. | -50.78 Million USD | -1150.853% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -706.074% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2823758.635% |
| GeoVax Labs, Inc. | -6.45 Million USD | -9744.529% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -217.898% |
| Biomea Fusion, Inc. | -166.57 Million USD | -281.357% |
| RenovoRx, Inc. | -1.17 Million USD | -54054.049% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -569.76% |
| Geron Corporation | 14.76 Million USD | 4403.414% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 14012.111% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -170.959% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -574.26% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -563.797% |
| Royalty Pharma plc | 5.65 Billion USD | 111.227% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -1525.744% |
| Imunon, Inc. | -4.21 Million USD | -14974.734% |
| BioAtla, Inc. | -109.01 Million USD | -482.718% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 5408.599% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -2895.93% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -351.377% |
| Structure Therapeutics Inc. | -124.33 Million USD | -410.883% |
| 89bio, Inc. | -289.05 Million USD | -119.761% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -3735.912% |
| aTyr Pharma, Inc. | -7.44 Million USD | -8427.682% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -409.666% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -676.761% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -73833.756% |
| Akari Therapeutics, Plc | -3.84 Million USD | -16420.858% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 39241.716% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 146.002% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 859.85% |
| Liquidia Corporation | -80.17 Million USD | -692.291% |
| Entera Bio Ltd. | -10.62 Million USD | -5876.357% |
| GH Research PLC | -78.07 Million USD | -713.59% |
| Vericel Corporation | 1.27 Million USD | 49843.696% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -3516.642% |
| Xencor, Inc. | 29.64 Million USD | 2242.852% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -32148.103% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3809.24% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -259273.724% |
| Vaxcyte, Inc. | -368.22 Million USD | -72.51% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -361.178% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -402.485% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -53364.211% |
| Portage Biotech Inc. | -4.98 Million USD | -12653.001% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2823758.635% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -860.689% |
| OncoCyte Corporation | -6.56 Million USD | -9578.912% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 70884.243% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -13843.74% |
| Purple Biotech Ltd. | -14.13 Million USD | -4393.047% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -3320.9% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -10740.051% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -979.932% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -2573.964% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -2664.741% |
| United Therapeutics Corporation | -507.7 Million USD | -25.119% |
| HilleVax, Inc. | -165.48 Million USD | -283.858% |
| Silo Pharma, Inc. | -3.52 Million USD | -17924.162% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 636797.772% |
| Pharming Group N.V. | 109.8 Million USD | 678.51% |
| Tharimmune, Inc. | -10.93 Million USD | -5708.931% |
| Genprex, Inc. | -6.73 Million USD | -9328.05% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -446.281% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -72.238% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 6330.77% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -45240.971% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -19050.96% |
| OKYO Pharma Limited | -826.84 Thousand USD | -76725.124% |
| Savara Inc. | 153 Thousand USD | 415281.046% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 5177.348% |
| Curis, Inc. | -23.88 Million USD | -2559.3% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -81757.884% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 53705.654% |
| BeiGene, Ltd. | -2.25 Billion USD | 71.806% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -242.282% |
| Erasca, Inc. | -37.21 Million USD | -1606.865% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -49222.964% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -49222.964% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -6036.273% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -5744.93% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1924.886% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1868.353% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -1747.879% |
| Adicet Bio, Inc. | -138.78 Million USD | -357.699% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 420.716% |
| Aditxt, Inc. | 18.12 Million USD | 3605.497% |
| Adagene Inc. | -87.62 Million USD | -624.918% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -15149.982% |
| Quantum-Si incorporated | -118.55 Million USD | -435.799% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -8398.943% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -1209.503% |
| Compugen Ltd. | -12.9 Million USD | -4822.714% |
| Generation Bio Co. | 31.44 Million USD | 2119.928% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -262.233% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1954.222% |
| Invivyd, Inc. | -198.47 Million USD | -220.052% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -603.697% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -26393.311% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -797.34% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -9207.355% |
| 2seventy bio, Inc. | 181.71 Million USD | 449.573% |
| Instil Bio, Inc. | 75.35 Million USD | 942.946% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -6893.81% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -20283.608% |
| GeoVax Labs, Inc. | -6.45 Million USD | -9744.529% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -2343.211% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -15425.274% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -12094.797% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -387.496% |
| Evaxion Biotech A/S | 5.28 Million USD | 12115.24% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -464.305% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -383.898% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -1133.211% |
| Cingulate Inc. | 3.08 Million USD | 20706.303% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -21528.43% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 8938.556% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -501.871% |
| Clearmind Medicine Inc. | -3.94 Million USD | -16011.729% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 6851.27% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 43664.587% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -1070.796% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 3776.508% |
| ImmunityBio, Inc. | 618.22 Million USD | 202.75% |
| Korro Bio, Inc. | -132.94 Million USD | -377.819% |
| Kineta, Inc. | -4.54 Million USD | -13888.703% |
| BioVie Inc. | -17.73 Million USD | -3482.306% |
| Codexis, Inc. | -43.27 Million USD | -1368.02% |
| Celularity Inc. | 65.19 Million USD | 1074.424% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 957.025% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -19945.03% |
| Virax Biolabs Group Limited | -3.36 Million USD | -18777.788% |
| Cibus, Inc. | -8.07 Million USD | -7763.667% |
| IN8bio, Inc. | -16.38 Million USD | -3775.935% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1764619.444% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -17982.18% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 160.253% |
| Eyenovia, Inc. | 1.25 Million USD | 50566.83% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 2461.0% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -19487.635% |
| Elevation Oncology, Inc. | -19.11 Million USD | -3222.665% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1810.63% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -3156.572% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -978.942% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -2964.732% |
| Moolec Science SA | 117.61 Thousand USD | 540185.533% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -1554.28% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -1575.265% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -349.174% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -2723.859% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -8988.403% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -11744.932% |
| Humacyte, Inc. | -22.48 Million USD | -2724.989% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -2416.548% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -35526.865% |
| Genelux Corporation | -6.89 Million USD | -9107.523% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1945.227% |
| Notable Labs, Ltd. | -9.77 Million USD | -6397.821% |
| Quantum-Si incorporated | -118.55 Million USD | -435.799% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -15232.537% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 8013.629% |
| Acasti Pharma Inc. | -23 Million USD | -2661.256% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -18764.978% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -275.257% |
| PepGen Inc. | -60.67 Million USD | -947.02% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -3221.275% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -73584.62% |
| Immuneering Corporation | -54.94 Million USD | -1056.159% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -15011.902% |
| Belite Bio, Inc | -87.27 Million USD | -627.879% |
| XOMA Corporation | -29 Million USD | -2090.438% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -798.52% |
| Bionomics Limited | 227 Million USD | 379.823% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -24978.05% |
| uniQure N.V. | -102.95 Million USD | -517.019% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -15149.982% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1651.188% |
| Forte Biosciences, Inc. | -11.96 Million USD | -5210.818% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -20429.604% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 599370.755% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -19487.635% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 7233.375% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -8465.628% |
| Altimmune, Inc. | -134.48 Million USD | -372.333% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -242.442% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -24978.05% |
| Peak Bio, Inc. | 10.34 Million USD | 6243.301% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -224361.837% |
| Benitec Biopharma Inc. | -50.58 Million USD | -1155.836% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -508.817% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 3333.53% |
| Zura Bio Limited | -99.8 Million USD | -536.462% |
| PolyPid Ltd. | 6.17 Million USD | 10395.413% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 3333.53% |
| argenx SE | -2.02 Billion USD | 68.69% |
| Immunome, Inc. | -97.02 Million USD | -554.677% |
| Verona Pharma plc | -220.44 Million USD | -188.159% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -785.42% |
| Shattuck Labs, Inc. | -121.42 Million USD | -423.148% |
| CervoMed Inc. | -7.79 Million USD | -8051.412% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -14426.115% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -382.182% |
| Moolec Science SA | 117.61 Thousand USD | 540185.533% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -27663.697% |
| Design Therapeutics, Inc. | -18.15 Million USD | -3399.873% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -802.555% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 5755.511% |
| Achilles Therapeutics plc | -126.92 Million USD | -400.478% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 43664.587% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -8437.997% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 286.723% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 2776.33% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -41.959% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -352.728% |
| Beam Therapeutics Inc. | -262.72 Million USD | -141.787% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 3011.748% |
| AEON Biopharma, Inc. | -4.88 Million USD | -12916.947% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -1037.095% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -536.118% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -26956.346% |
| NeurAxis, Inc. | 145.7 Thousand USD | 436082.841% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -1527.702% |
| Lumos Pharma, Inc. | -28.49 Million USD | -2129.414% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -2957.824% |
| Palisade Bio, Inc. | -12.06 Million USD | -5165.912% |
| Nutriband Inc. | -251.65 Thousand USD | -252317.775% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -662.742% |
| Neurogene Inc. | -131.95 Million USD | -381.397% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -12840.049% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -68.41% |
| Athira Pharma, Inc. | -88.99 Million USD | -613.746% |
| HCW Biologics Inc. | 2.85 Million USD | 22336.578% |
| XOMA Corporation | -29 Million USD | -2090.438% |
| Nektar Therapeutics | 210.24 Million USD | 402.144% |
| Arvinas, Inc. | -313.8 Million USD | -102.431% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 39241.716% |
| Merus N.V. | -192.88 Million USD | -229.331% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 1158.976% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -9055.765% |
| Rezolute, Inc. | -68.16 Million USD | -831.855% |
| Clene Inc. | 3.34 Million USD | 19118.772% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -4717.07% |
| BeyondSpring Inc. | -13.75 Million USD | -4518.153% |
| Synlogic, Inc. | -6.68 Million USD | -9402.274% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 56116.49% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -7413.034% |
| Peak Bio, Inc. | 10.34 Million USD | 6243.301% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -670.719% |
| Krystal Biotech, Inc. | -350.23 Million USD | -81.372% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 611.764% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -275.883% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -20020.305% |
| MannKind Corporation | 143.89 Million USD | 541.439% |
| Ikena Oncology, Inc. | -109.15 Million USD | -481.944% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -8290.265% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1819.115% |
| Gossamer Bio, Inc. | 180.35 Million USD | 452.209% |
| CohBar, Inc. | -5.93 Million USD | -10610.771% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -2035.36% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 14012.111% |
| Legend Biotech Corporation | -949.39 Million USD | 33.092% |
| Mural Oncology plc | -255.84 Million USD | -148.288% |
| Disc Medicine, Inc. | -358.28 Million USD | -77.299% |
| Champions Oncology, Inc. | 4.81 Million USD | 13300.894% |
| REGENXBIO Inc. | 54.76 Million USD | 1259.851% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -236125.535% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -320.613% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -6948.675% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -687.312% |
| Vaxart, Inc. | -8.24 Million USD | -7608.13% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -1165.898% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -399.527% |
| Cellectis S.A. | -43.85 Million USD | -1348.471% |
| Longeveron Inc. | -2.9 Million USD | -21744.12% |
| Repare Therapeutics Inc. | -107.85 Million USD | -488.948% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 165.597% |
| Inozyme Pharma, Inc. | 12 Million USD | 5391.794% |
| Revolution Medicines, Inc. | -608.2 Million USD | -4.443% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -51544.472% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -139.603% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -323.281% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -3959.737% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -85741.486% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 93.358% |
| Denali Therapeutics Inc. | -74.86 Million USD | -748.497% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -5197.222% |
| Veru Inc. | 4.77 Million USD | 13389.354% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -5548.471% |
| Cingulate Inc. | 3.08 Million USD | 20706.303% |
| Passage Bio, Inc. | 4.58 Million USD | 13954.46% |
| Context Therapeutics Inc. | -14.44 Million USD | -4296.087% |
| Exicure, Inc. | 5.84 Million USD | 10960.438% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -175.735% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -1505.325% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 4148.353% |
| Nuvalent, Inc. | -335.38 Million USD | -89.401% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 36726.419% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -752.86% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -7045.411% |
| OmniAb, Inc. | 9.2 Million USD | 7002.391% |
| Anew Medical, Inc. | 1.43 Million USD | 44445.028% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 3977.649% |
| Lipocine Inc. | -4.75 Million USD | -13260.284% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -478.383% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 4270.619% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1153.927% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 2651.932% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -9351.376% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -864.995% |
| Ocugen, Inc. | -32.52 Million USD | -1853.282% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -642.304% |
| Q32 Bio Inc. | -37.94 Million USD | -1573.941% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -101050.796% |
| Alumis Inc. Common Stock | -13.52 Million USD | -4595.299% |
| Equillium, Inc. | -22.39 Million USD | -2736.848% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -2384.461% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1846.95% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -256127.739% |
| Dominari Holdings Inc. | 195 Thousand USD | 325857.436% |
| Edesa Biotech, Inc. | -5.26 Million USD | -11960.715% |
| vTv Therapeutics Inc. | -8.91 Million USD | -7023.775% |
| Bio-Techne Corporation | 267.74 Million USD | 337.249% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -3818.977% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -437.899% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -7459.526% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -4921.16% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -159.15% |
| Nkarta, Inc. | 57.29 Million USD | 1208.618% |
| BioCardia, Inc. | 212 Thousand USD | 299735.377% |
| Iterum Therapeutics plc | 13.43 Million USD | 4827.095% |